MDT

99.7

-0.07%↓

A

145.92

+0.05%↑

VEEV

238.84

+1.15%↑

HQY

97.7

+3.12%↑

PHR.US

17.49

+1.22%↑

MDT

99.7

-0.07%↓

A

145.92

+0.05%↑

VEEV

238.84

+1.15%↑

HQY

97.7

+3.12%↑

PHR.US

17.49

+1.22%↑

MDT

99.7

-0.07%↓

A

145.92

+0.05%↑

VEEV

238.84

+1.15%↑

HQY

97.7

+3.12%↑

PHR.US

17.49

+1.22%↑

MDT

99.7

-0.07%↓

A

145.92

+0.05%↑

VEEV

238.84

+1.15%↑

HQY

97.7

+3.12%↑

PHR.US

17.49

+1.22%↑

MDT

99.7

-0.07%↓

A

145.92

+0.05%↑

VEEV

238.84

+1.15%↑

HQY

97.7

+3.12%↑

PHR.US

17.49

+1.22%↑

Search

IQVIA Holdings Inc

Open

SectorGezondheidszorg

244.59 3.32

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

235.88

Max

245.7

Belangrijke statistieken

By Trading Economics

Inkomsten

66M

332M

Verkoop

83M

4.1B

K/W

Sectorgemiddelde

30.949

88.032

Winstmarge

8.098

Werknemers

91,000

EBITDA

102M

883M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+4.18% upside

Dividenden

By Dow Jones

Volgende Winsten

5 feb 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

2.5B

40B

Vorige openingsprijs

241.27

Vorige sluitingsprijs

244.59

Nieuwssentiment

By Acuity

68%

32%

345 / 373 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

IQVIA Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

6 jan 2026, 21:14 UTC

Belangrijke Marktbewegers

Ventyx Biosciences Gains on Report of Possible $1 Billion Eli Lilly Deal

6 jan 2026, 19:23 UTC

Acquisities, Fusies, Overnames

OneStream to Go Private Through $6.4 Billion Hg Acquisition

6 jan 2026, 17:41 UTC

Belangrijke Marktbewegers

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

6 jan 2026, 15:46 UTC

Acquisities, Fusies, Overnames

Advent International Leads InPost Takeover Offer, Sky News Says

6 jan 2026, 15:37 UTC

Belangrijke Marktbewegers

Terrestrial Energy Shares Rise After DOE Agreement For Nuclear Plant Development

6 jan 2026, 23:46 UTC

Marktinformatie

Nikkei May Decline After Hitting Record High -- Market Talk

6 jan 2026, 23:35 UTC

Marktinformatie

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

6 jan 2026, 23:19 UTC

Marktinformatie

Greatland 2Q Gold Output Strong, Sales Soft -- Market Talk

6 jan 2026, 22:53 UTC

Marktinformatie

WiseTech, REA and CAR Look Best Insulated From AI Threat -- Market Talk

6 jan 2026, 22:03 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 jan 2026, 22:03 UTC

Acquisities, Fusies, Overnames

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

6 jan 2026, 21:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

6 jan 2026, 21:12 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

6 jan 2026, 21:12 UTC

Marktinformatie

Commodity Demand Helps Canada Reduce Reliance on Trade With U.S. -- Market Talk

6 jan 2026, 20:59 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

6 jan 2026, 20:40 UTC

Acquisities, Fusies, Overnames

Acquisition of Ventyx Would Bring Lilly Into Emerging Category of Pills for Inflammation-Related Conditions -- WSJ

6 jan 2026, 20:40 UTC

Acquisities, Fusies, Overnames

Eli Lilly Nears Deal for Biotech Ventyx -- WSJ

6 jan 2026, 20:40 UTC

Acquisities, Fusies, Overnames

Deal Could Be Announced Imminently, Sources Say -- WSJ

6 jan 2026, 20:40 UTC

Acquisities, Fusies, Overnames

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences For Over $1B, Sources Say -- WSJ

6 jan 2026, 20:01 UTC

Marktinformatie

Oil Futures Give Back Post-Venezuela Incursion Gains -- Market Talk

6 jan 2026, 19:52 UTC

Marktinformatie

U.S. Natural Gas Falls Awaiting Colder Weather -- Market Talk

6 jan 2026, 19:46 UTC

Acquisities, Fusies, Overnames

Under Armour Stock Rises After the 'Warren Buffet of Canada' Boosts Its Stake -- Barrons.com

6 jan 2026, 19:08 UTC

Acquisities, Fusies, Overnames

OneStream to Go Private Through $6.4B Hg Acquisition

6 jan 2026, 18:28 UTC

Acquisities, Fusies, Overnames

These Stocks Are Moving the Most Today: Sandisk, Nvidia, AMD, Palantir, OneStream, SoFi, Microchip, and More -- Barrons.com

6 jan 2026, 17:20 UTC

Marktinformatie
Winsten

Financial Services Roundup: Market Talk

6 jan 2026, 17:20 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Health Care Roundup: Market Talk

6 jan 2026, 15:57 UTC

Marktinformatie

Crude Futures Ease Back From Early Gains -- Market Talk

6 jan 2026, 15:34 UTC

Marktinformatie
Winsten

Bank of Montreal Expects to Exit 2027 With ROE Hitting 15% Target -- Market Talk

6 jan 2026, 15:27 UTC

Marktinformatie

German Inflation Won't Fall Much Further in 2026 -- Market Talk

Peer Vergelijking

Prijswijziging

IQVIA Holdings Inc Prognose

Koersdoel

By TipRanks

4.18% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 250.58 USD  4.18%

Hoogste 273 USD

Laagste 215 USD

Gebaseerd op 15 Wall Street-analisten die 12-maands prijsdoelen bieden voor IQVIA Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

15 ratings

12

Buy

3

Hold

0

Sell

Technische score

By Trading Central

150.68 / 153.45Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Neutral Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

345 / 373 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.
help-icon Live chat